Buy, Sell or Hold? before and after EPS results NYSE:BEST, NASDAQ:CREE, NYSE:CZZ, NASDAQ:PSTX

0
224

BEST (NYSE:BEST) EARNINGS INFORMATION (NYSE:BEST)

BEST last announced its quarterly earnings results on August 17th, 2020. The reported $0.05 EPS for the quarter, beating analysts’ consensus estimates of ($0.13) by $0.18. The company had revenue of $8.42 billion for the quarter, compared to analyst estimates of $8.95 billion. Its revenue was down 4.2% on a year-over-year basis. BEST has generated ($0.07) earnings per share over the last year. BEST has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Wednesday, November 11th, 2020 based off prior year’s report dates.

HOW HAS BEST’S STOCK PRICE BEEN IMPACTED BY CORONAVIRUS? (NYSE:BEST)

BEST’s stock was trading at $4.97 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, BEST shares have decreased by 16.1% and is now trading at $4.17.

CREE (NASDAQ:CREE) EARNINGS INFORMATION (NASDAQ:CREE)

Cree last announced its earnings data on August 18th, 2020. The LED producer reported ($0.18) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.19) by $0.01. The firm had revenue of $205.70 million for the quarter, compared to the consensus estimate of $198.57 million. Its revenue for the quarter was down 18.0% compared to the same quarter last year. Cree has generated ($0.87) earnings per share over the last year. Cree has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Wednesday, November 4th, 2020 based off prior year’s report dates.

HOW HAS CREE’S STOCK PRICE BEEN IMPACTED BY COVID-19? (NASDAQ:CREE)

Cree’s stock was trading at $35.34 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, CREE shares have increased by 70.8% and is now trading at $60.37.

COSAN (NYSE:CZZ) EARNINGS INFORMATION (NYSE:CZZ)

Cosan last released its quarterly earnings results on June 4th, 2020. The basic materials company reported $2.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.98 by $1.83. The firm had revenue of $1.11 billion for the quarter. Cosan has generated $1.34 earnings per share over the last year and currently has a price-to-earnings ratio of 13.4. Cosan has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Wednesday, November 11th, 2020 based off prior year’s report dates.

HOW HAS COSAN’S STOCK BEEN IMPACTED BY COVID-19 (CORONAVIRUS)? (NYSE:CZZ)

Cosan’s stock was trading at $14.75 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, CZZ shares have increased by 21.6% and is now trading at $17.93.

POSEIDA THERAPEUTICS (NASDAQ:PSTX) EARNINGS INFORMATION (NASDAQ:PSTX)

Poseida Therapeutics last announced its earnings data on August 20th, 2020. The reported ($2.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.15) by $1.13. Poseida Therapeutics has generated $0.00 earnings per share over the last year. Poseida Therapeutics has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Thursday, November 19th, 2020 based off prior year’s report dates.

DO WALL STREET ANALYSTS RECOMMEND INVESTORS BUY SHARES OF POSEIDA THERAPEUTICS? (NASDAQ:PSTX)

4 Wall Street analysts have issued “buy,” “hold,” and “sell” ratings for Poseida Therapeutics in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of “Buy.”
View analyst ratings for Poseida Therapeutics.